NPI: 1922075670 · DES MOINES, IA 50316 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/01/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/01/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,524 | $98K |
| 2019 | 5,058 | $102K |
| 2020 | 14,337 | $129K |
| 2021 | 16,058 | $280K |
| 2022 | 9,281 | $193K |
| 2023 | 2,859 | $168K |
| 2024 | 2,222 | $204K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 25,613 | 1,607 | $1.03M |
| 90945 | 3,964 | 126 | $84K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,457 | 634 | $37K |
| J1270 | Injection, doxercalciferol, 1 mcg | 2,997 | 203 | $8K |
| J1756 | Injection, iron sucrose, 1 mg | 2,242 | 495 | $6K |
| A4657 | Syringe, with or without needle, each | 2,076 | 841 | $3K |
| 83970 | 629 | 341 | $1K | |
| 82728 | 539 | 308 | $493.77 | |
| 83550 | 525 | 294 | $315.58 | |
| 83540 | 525 | 294 | $239.43 | |
| 85041 | 1,181 | 647 | $220.70 | |
| 85048 | 1,152 | 632 | $176.65 | |
| 90674 | 47 | 25 | $88.04 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 21 | 12 | $28.12 |
| G0008 | Administration of influenza virus vaccine | 42 | 25 | $10.36 |
| A9270 | Non-covered item or service | 204 | 36 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 125 | 51 | $0.00 |